Tarsus Pharmaceuticals (TARS)
NASDAQ:TARS
Tarsus Pharmaceuticals (TARS) Ownership Overview
3.27% Insiders
23.59% Mutual Funds
50.41% Other Institutional Investors
12.29% ETFs
10.45% Public Companies and
Individual Investors
The ownership structure of Tarsus Pharmaceuticals (TARS) stock is a mix of institutional, retail, and individual investors. Approximately 86.28% of the company’s stock is owned by Institutional Investors, 3.27% is owned by Insiders, and 10.45% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 19, 2026 | xxxxxxxxxxxxx | $772444 | |
Mar 19, 2026 | xxxxxxxxxxxxx | $892528 | |
Mar 19, 2026 | xxxxxxxxxxxxx | $839070 | |
Mar 19, 2026 | xxxxxxxxxxxxx | $850417 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2023 | xxxxxxxxxxxxx | $1375584 | |
Dec 31, 2023 | xxxxxxxxxxxxx | $95998323 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,035,448 | Institution | 4.78% | 131,306,750 | |
| 1,937,361 | Institution | 4.55% | 124,979,158 | |
| 1,712,375 | Institution | 4.02% | 110,465,311 | |
| 1,172,427 | Institution | 2.75% | 75,633,266 | |
| 1,095,688 | Institution | 2.57% | 70,682,833 | |
| 891,412 | Insider | 2.09% | 57,504,988 | |
| 651,332 | Institution | 1.53% | 42,017,427 | |
| 512,819 | Institution | 1.21% | 33,081,954 | |
| 472,002 | Institution | 1.11% | 30,448,849 | |
| 427,284 | Institution | 1.00% | 27,564,091 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,712,375 | Institution | 4.02% | 110,465,311 | |
| 1,095,688 | Institution | 2.57% | 70,682,833 | |
| 651,332 | Institution | 1.53% | 42,017,427 | |
| 512,819 | Institution | 1.21% | 33,081,954 | |
| 472,002 | Institution | 1.11% | 30,448,849 | |
| 427,284 | Institution | 1.00% | 27,564,091 | |
| 390,000 | Institution | 0.92% | 25,158,900 | |
| 385,753 | Institution | 0.91% | 24,884,926 | |
| 374,184 | Institution | 0.88% | 24,138,610 | |
| 360,530 | Institution | 0.85% | 23,257,790 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,273,472 | Institution | 2.99% | 96,172,605 | |
| 962,391 | Institution | 2.26% | 62,083,843 | |
| 425,966 | Institution | 1.00% | 32,168,952 | |
| 329,150 | Institution | 0.77% | 21,233,467 | |
| 283,852 | Institution | 0.67% | 18,311,293 | |
| 194,040 | Institution | 0.46% | 14,653,901 | |
| 190,083 | Institution | 0.45% | 12,688,040 | |
| 158,138 | Institution | 0.37% | 10,201,482 | |
| 103,695 | Institution | 0.24% | 6,689,364 | |
| 96,038 | Institution | 0.23% | 7,252,790 |
FAQ
Who Owns Tarsus Pharmaceuticals (TARS)?
According to the latest TipRanks data, approximately 50.41% of the company's stock is held by institutional investors, 3.27% is held by insiders, and 10.45% is held by retail investors.
What percentage of Tarsus Pharmaceuticals (TARS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 50.41% of Tarsus Pharmaceuticals (TARS) stock is held by institutional investors.
What percentage of Tarsus Pharmaceuticals (TARS) stock is held by retail investors?
According to the latest TipRanks data, approximately 10.45% of Tarsus Pharmaceuticals (TARS) stock is held by retail investors.
Who owns the most shares of Tarsus Pharmaceuticals (TARS)?
Vanguard owns the most shares of Tarsus Pharmaceuticals (TARS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.